These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8426513)

  • 1. Fibrin binding, fibrinolytic and fibrinogenolytic activity of plasminogen activator derived from the paranasal mucous membrane of humans.
    Yamashiro Y; Nakamura M; Huang GW; Kosugi T
    Laryngoscope; 1993 Feb; 103(2):197-202. PubMed ID: 8426513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some chemical properties of tissue plasminogen activator purified from paranasal mucous membrane.
    Kosugi T; Nakamura M; Tsukayama T; Haraguchi S; Noda Y
    Rhinology; 1987 Jun; 25(2):129-32. PubMed ID: 3112919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitro.
    Samama M; Nguyen G; Desnoyers P; Lourenco DM; Fretault J; Horellou MH; Conard J; Szwarcer E; Verdy E; Vahanian A
    Fundam Clin Pharmacol; 1988; 2(6):509-23. PubMed ID: 3149257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of tissue plasminogen activator from paranasal mucous membrane in chronic sinusitis.
    Kosugi T; Matsuo O; Mihara H; Hirano K; Hamaya M
    Ann Otol Rhinol Laryngol; 1982; 91(1 Pt 1):101-5. PubMed ID: 7041770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of urokinase-type plasminogen activator (u-PA) in tissue extracts of antrochoanal polyp.
    Yamashiro Y; Nakamura M; Huang GW; Kosugi T
    Laryngoscope; 1992 Sep; 102(9):1049-52. PubMed ID: 1518351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin.
    Dewerchin M; Lijnen HR; Van Hoef B; De Cock F; Collen D
    Eur J Biochem; 1989 Oct; 185(1):141-9. PubMed ID: 2530085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of proactivator from tissue plasminogen activator with low molecular weight in the paranasal mucous membrane.
    Kosugi T; Takagi I; Ariga Y; Kinjo K; Matayoshi S; Noda Y
    Auris Nasus Larynx; 1982; 9(2):99-104. PubMed ID: 6891585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.
    Holvoet P; Laroche Y; Lijnen HR; Van Hoef B; Brouwers E; De Cock F; Lauwereys M; Gansemans Y; Collen D
    Eur J Biochem; 1992 Dec; 210(3):945-52. PubMed ID: 1483477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity.
    Gurewich V; Pannell R
    Thromb Res; 1986 Oct; 44(2):217-28. PubMed ID: 3097872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional effects of asparagine-linked oligosaccharide on natural and variant human tissue-type plasminogen activator.
    Hansen L; Blue Y; Barone K; Collen D; Larsen GR
    J Biol Chem; 1988 Oct; 263(30):15713-9. PubMed ID: 3139674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasminogen activators: general aspects and recent developments].
    Reboud-Ravaux M
    Biochimie; 1985 Dec; 67(12):1197-216. PubMed ID: 3913465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator.
    Bode C; Runge MS; Schönermark S; Eberle T; Newell JB; Kübler W; Haber E
    Circulation; 1990 Jun; 81(6):1974-80. PubMed ID: 2111744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in physicochemical properties between tissue plasminogen activators from human paranasal mucous membrane and pig heart.
    Kosugi T; Takagi I; Matsuo O; Mihara H; Morimitsu T; Hirano K; Hamaya M
    Auris Nasus Larynx; 1981; 8(2):77-86. PubMed ID: 7199907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.
    Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ
    Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
    Electricwala A; Ling RJ; Sutton PM; Griffiths B; Riley PA; Atkinson T
    Thromb Haemost; 1985 Apr; 53(2):200-3. PubMed ID: 4040659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.